Hypogonadism Clinical Trials

A listing of Hypogonadism medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Vestavia Hills Alabama

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism

Arizona

Watching Over Mothers and Babies
Tucson Arizona

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Arkansas

Little Rock Arkansas

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism

California

UCSF Center for Reproductive Health
San Francisco California

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

Torrance California 90502

A Phase 1/Phase 2 clinical study for patients with Hypogonadism

Colorado

University of Colorado School of Medicine
Aurora Colorado

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Delaware

Reproductive Associates of Delaware
Newark Delaware

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

District of Columbia

Columbia Fertility Associates
Washington District of Columbia

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Florida

Women's Medical Research Group
Clearwater Florida

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Center for Reproductive Medicine
Orlando Florida

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

Deland Florida

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism

Homestead Florida

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism

Georgia

Georgia Reproductive Specialists
Atlanta Georgia

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Idaho

Meridian Idaho

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism

Illinois

Fertility Centers of Illinois
Chicago Illinois

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

Gurnee Illinois

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism

Northbrook Illinois 60062

Patients are needed to participate in a clinical research study evaluating Oral Testosterone Undecanoate and Axiron Testosterone Topical Solution for the treatment of Hypogonadism

Kansas

Cypress Medical Research Center
Wichita Kansas

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Maine

Maine Medical Center
Portland Maine

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Maryland

Elkridge Maryland

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism

Massachusetts

Massachusetts General Hospital
Boston Massachusetts

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

Boston Massachusetts 02114

A clinical research study of Testosterone, Anastrazole and Goserelin acetate for the treatment of Healthy Volunteers

Boston Massachusetts 02114

A clinical trial to evaluate treatments using Testosterone, Alendronate, Placebo Alendronate and Placebo Testosterone for patients with Hypogonadism, Osteopenia or Osteoporosis

Michigan

Wayne State University
Southfield Michigan

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

New Jersey

New York

Weill Cornell Medical Center
New York New York

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

Bronx New York 10468

A clinical research study of Testosterone Gel for the treatment of Pain or Hypogonadism

Great Neck New York

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism

New York New York 10028

A clinical trial seeking patients for a research study for the treatment of Hypogonadism

Rochester New York

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism

Williamsville New York 14221

A clinical trial seeking patients for a research study for the treatment of Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism

North Carolina

Carolinas Medical Center
Charlotte North Carolina

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

PMG Research of Charlotte
Charlotte North Carolina 28209

Low Testosterone associated with Hypogonadism

Lyndhurst Clinical Research
Winston-Salem North Carolina

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Wake Forest University Health Sciences
Winston-Salem North Carolina

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

Raleigh North Carolina

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism

Ohio

Institute for Reproductive Health
Cincinnati Ohio

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

University of Cincinnati Physicians
Cincinnati Ohio

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

University Hospitals Fertility Center
Cleveland Ohio

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Ohio Reproductive Medicine
Columbus Ohio

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Oklahoma

University of Oklahoma Health Sciences Center
Oklahoma City Oklahoma

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Pennsylvania

Abington Reproductive Medicine
Abington Pennsylvania

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Main Line Fertility Center
Bryn Mawr Pennsylvania

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Penn State MS Hershey Medical Center, Penn State College of Medicine
Hershey Pennsylvania

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Tennessee

Fertility Associates of Memphis
Memphis Tennessee

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Texas

Center for Assisted Reproduction
Bedford Texas

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Houston Fertility Institute
Houston Texas

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Center of Reproductive Medicine
Webster Texas

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Utah

Utah Fertility Center
Pleasant Grove Utah

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

West Jordan Utah

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism